Comparative effects of carrier proteins on vaccine-induced immune responseKNUF, Markus; KOWALZIK, Frank; KIENINGER, Dorothee et al.Vaccine. 2011, Vol 29, Num 31, pp 4881-4890, issn 0264-410X, 10 p.Article

The need for quadrivalent vaccine against seasonal influenzaBELSHE, Robert B.Vaccine. Supplement. 2010, Vol 28, Num 4, issn 1359-5938, D45-D53Article

Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of ageBLACK, S; KLEIN, N. P; SHAH, J et al.Vaccine. 2010, Vol 28, Num 3, pp 657-663, issn 0264-410X, 7 p.Article

Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)CROXTALL, Jamie D; DHILLON, Sohita.Drugs (Basel). 2012, Vol 72, Num 18, pp 2407-2430, issn 0012-6667, 24 p.Article

A new challenge for Europe : introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicellaRAMET, José.International journal of infectious diseases. 2007, Vol 11, issn 1201-9712, S49-S55, SUP2Article

Inactivated Quadrivalent Split-Virus Seasonal Influenza Vaccine (Fluarix^® Quadrivalent): A Review of Its Use in the Prevention of Disease Caused by Influenza A and BMCKEAGE, Kate.Drugs (Basel). 2013, Vol 73, Num 14, pp 1587-1594, issn 0012-6667, 8 p.Article

The Australian Experience With the Human Papillomavirus VaccineGARLAND, Suzanne M.Clinical therapeutics. 2014, Vol 36, Num 1, pp 17-23, issn 0149-2918, 7 p.Article

The Prophylactic Role for the Human Papillomavirus Quadrivalent Vaccine in MalesYANCEY, Abigail M; PITLICK, Jamie M; FORINASH, Alicia B et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 7-8, pp 1314-1318, issn 1060-0280, 5 p.Article